Hatch Biofund

Hatch Biofund is an early-stage life sciences venture capital firm based in Doylestown, Pennsylvania, operating as the investment arm of the Pennsylvania Biotechnology Center (PABC). The firm invests exclusively in private companies developing therapeutics and vaccines for human use, spanning all treatment modalities from small molecules to cell and gene therapy, with a preference for capital efficiency, well-understood disease biology, and clear development pathways. Hatch targets seed and Series A rounds, and the fund has sought to raise $50 million. Portfolio investments include companies such as Ladder Bio, MasterSwitch Bio, and ViTToria Biotherapeutics in the biotechnology and drug discovery sectors. The firm is closely tied to the PABC ecosystem, including the Hatch BioAccelerator Program, which provides concept-stage entrepreneurs with seed capital, lab space, and business creation services on the PABC campus. Founders in the therapeutics and vaccines space seeking early-stage capital with access to physical infrastructure and deep pharmaceutical industry networks should consider Hatch Biofund.